The report provides value (USD million), volume (units) and average price (USD) data for each sector and sub-segment within six industry categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants with data on company key figures and new product development, wherever available.


Scope of the Research

- Industry size and market share data for Neurology Devices industry categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
- Annualized industry revenues (USD million), volume (units) and average price (USD) data for each of the sectors and sub-segments within six industry categories. Data from 2003 to 2010, projection forward for 7 years to 2017.
- 2010 industry player shares and distribution shares data for each of the six industry categories.
- Global corporate-level profiles of key industry players operating within the United States Neurology Devicesmarket.
- Key Companies covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cyberonics, Inc., DePuy, Inc., Integra LifeSciences Holdings Corporation and others.

Why Should You Get This Report?

- Develop innovative strategies by selecting the key market segment expected to grow .
- Develop successful market-entry strategies .
- Understand and respond to your competition by identifying who-stands-where in the United States Neurology Devices competitive landscape.
- Facilitate better investment decision making by identifying the key industry sectors expected to register strong growth in the near future.
- What are the best distribution channels and what’s the most preferred mode of product distribution – Identify, understand and decide.

Table Of Contents

1 Table of Contents

I Table of Contents 2
I. 1 List of Data tables 9
I. 2 List of Charts 13

II Introduction 15
II. 1 About this Report and the Author 15

III Neurology Devices In United States 16
III. 1 Neurology Devices, March ket Segmentation 16
III. 2 Neurology Devices, United States, Overall Sales (USD Million), from 2003 to 2017 17
III. 3 Neurology Devices March ket, United States, Sales Mix (USD Million), 2010 19
III. 4 Neurology Devices March ket, United States, Segment Contribution (%), 2010 20
III. 5 Neurology Devices, United States, Segment Volume (Units), from 2003 to 2017 26
III. 6 Neurology Devices, United States, Market Shares (2009-2010) 31

IV CSF Management In United States 33
IV. 1 CSF Management, March ket Segmentation 33
IV. 2 CSF Management March ket, United States, Sales Mix (USD Million), 2010 34
IV. 3 CSF Management March ket, United States, Segment Contribution (%), 2010 35
IV. 4 CSF Management Overall Sales (2003-2017) 36
IV. 5 CSF Management Overall Volume (2003-2017) 40
IV. 6 CSF Management Average Price (2003-2017) 43
IV. 7 CSF Management Distribution Channel (2009-2010) 44
IV. 8 CSF Management, United States, Market Shares (2009-2010) 45

V Interventional Neurology In United States 46
V. 1 Interventional Neurology, March ket.Segmentation 46
V. 2 Interventional Neurology March ket, United States, Sales Mix (USD Million), 2010 47
V. 3 Interventional Neurology March ket, United States, Segment Contribution (%), 2010 48
V. 4 Interventional Neurology Overall Sales (2003-2017) 49
V. 4.1 Embolic Systems Sales from 2003 to 2010 53
V. 4.2 Navigational Systems Sales from 2003 to 2010 57
V. 5 Interventional Neurology Overall Volume (2003-2017) 61
V. 5.1 Embolic Systems Volume from 2003 to 2010 65
V. 5.2 Navigational Systems Volume (Units) from 2003 to 2010 67
V. 6 Interventional Neurology Average Price (2003-2017) 71
V. 7 Interventional Neurology Distribution Channel (2009-2010) 72
V. 8 Interventional Neurology, United States, Market Shares (2009-2010) 73

VI Neurological Diagnostic Equipment In United States 75
VI. 1 Neurological Diagnostic Equipment, March ket.Segmentation 75
VI. 2 Neurological Diagnostic Equipment March ket, United States, Sales Mix (USD Million), 2010 76
VI. 3 Neurological Diagnostic Equipment March ket, United States, Segment Contribution (%), 2010 77
VI. 4 Neurological Diagnostic Equipment Overall Sales (2003-2017) 78
VI. 5 Neurological Diagnostic Equipment Overall Volume (2003-2017) 82
VI. 6 Neurological Diagnostic Equipment Average Price (2003-2017) 86
VI. 7 Neurological Diagnostic Equipment Distribution Channel (2009-2010) 87
VI. 8 Neurological Diagnostic Equipment, United States, Market Shares (2009-2010) 88

VII Neurostimulation Devices In United States 90
VII. 1 Neurostimulation Devices, March ket Segmentation 90
VII. 2 Neurostimulation Devices March ket, United States, Sales Mix (USD Million), 2010 91
VII. 3 Neurostimulation Devices March ket, United States, Segment Contribution (%), 2010 92
VII. 4 Neurostimulation Devices Overall Sales (2003-2017) 93
VII. 5 Neurostimulation Devices Overall Volume (2003-2017) 97
VII. 6 Neurostimulation Devices Average Price (2003-2017) 101
VII. 7 Neurostimulation Devices Distribution Channel (2009-2010) 102
VII. 8 Neurostimulation Devices, United States, Market Shares (2009-2010) 103

VIII Neurosurgical Products In United States 105
VIII. 1 Neurosurgical Products, March ket Segmentation 105
VIII. 2 Neurosurgical Products March ket, United States, Sales Mix (USD Million), 2010 106
VIII. 3 Neurosurgical Products March ket, United States, Segment Contribution (%), 2010 107
VIII. 4 Neurosurgical Products Overall Sales (2003-2017) 108
VIII. 5 Neurosurgical Products Overall Volume (2003-2017) 112
VIII. 6 Neurosurgical Products Average Price (2003-2017) 115
VIII. 7 Neurosurgical Products Distribution Channel (2009-2010) 116
VIII. 8 Neurosurgical Products, United States, Market Shares (2009-2010) 117

IX Radiosurgery In United States 119
IX. 1 Radiosurgery, March ket Segmentation 119
IX. 2 Radiosurgery March ket, United States, Sales Mix (USD Million), 2010 120
IX. 3 Radiosurgery March ket, United States, Segment Contribution (%), 2010 121
IX. 4 Radiosurgery Overall Sales (2003-2017) 122
IX. 5 Radiosurgery Overall Volume (2003-2017) 126
IX. 6 Radiosurgery Average Price (2003-2017) 129
IX. 7 Radiosurgery Distribution Channel (2009-2010) 130
IX. 8 Radiosurgery, United States, Market Shares (2009-2010) 131

X Overview of Key Firms in United States Neurology Devices March ket 132
X. 1 Medtronic, Inc. 132
X. 1.1 Company Profile 132
X. 1.2 Share in the United States Neurology Devices March ket 132
X. 2 Boston Scientific Corporation 133
X. 2.1 Company Profile 133
X. 2.2 Share in the United States Neurology Devices March ket 133
X. 3 St. Jude Medical, Inc. 134
X. 3.1 Company Profile 134
X. 3.2 Share in the United States Neurology Devices March ket 134
X. 4 Cyberonics, Inc. 135
X. 4.1 Company Profile 135
X. 4.2 Share in the United States Neurology Devices March ket 135
X. 5 DePuy, Inc. 136
X. 5.1 Company Profile 136
X. 5.2 Share in the United States Neurology Devices March ket 136
X. 6 Integra LifeSciences Holdings Corporation 137
X. 6.1 Company Profile 137
X. 6.2 Share in the United States Neurology Devices March ket 137
X. 7 Terumo Corporation 138
X. 7.1 Company Profile 138
X. 8 Nihon Kohden Corporation 138
X. 8.1 Company Profile 138
X. 9 Elekta AB 139
X. 9.1 Company Profile 139
X. 10 Micrus Endovascular Corporation 139
X. 10.1 Company Profile 139
X. 11 Cadwell Laboratories, Inc. 139
X. 11.1 Company Profile 139
X. 12 ev3 Inc. 140
X. 12.1 Company Profile 140
X. 13 B. Braun Melsungen AG 140
X. 13.1 Company Profile 140
X. 14 Mizuho Ikakogyo Co., Ltd. 140
X. 14.1 Company Profile 140
X. 15 Accuray Incorporated 141
X. 15.1 Company Profile 141
X. 16 CareFusion Corporation 141
X. 16.1 Company Profile 141
X. 17 Natus Medical Incorporated 141
X. 17.1 Company Profile 141
X. 18 Covidien plc 142
X. 18.1 Company Profile 142
X. 19 Sophysa S.A. 142
X. 19.1 Company Profile 142
X. 20 KARL STORZ GmbH and Co. KG 142
X. 20.1 Company Profile 142

XI Neurology Devices March ket Pipeline Products 143

XII Financial Deals Landscape 150
XII. 1 Acquisition 150
XII. 1.1 Impulse Monitoring Takes Over Great Lakes Intraoperative Neuromonitoring 150
XII. 1.2 Boston Scientific Takes Over Remaining Stake In Intelect Medical 151
XII. 1.3 Vycor Medical Completes Acquisition Of November aVision 153
XII. 1.4 Synthes Takes Over The Anspach Effort 154
XII. 1.5 Stryker Takes Over Porex Surgical 155
XII. 1.6 Cardinal Health Sells 13.7% Stake In Carefusion 156
XII. 1.7 HealthMed Services Takes Over Neural Communicator 157
XII. 1.8 Masimo Completes Acquisition Of SEDLine 158
XII. 1.9 Johnson and Johnson Completes Acquisition Of Micrus Endovascular 159
XII. 1.10 K-Kitz Takes Over Bacterin In Reverse Acquisition 161
XII. 1.11 Medtronic Takes Over Axon Systems 162
XII. 1.12 Covidien Completes Acquisition Of ev3 For US$ 2.6 Bln 163
XII. 2 Partner agreements 165
XII. 2.1 Boston Scientific Enters Into Partnership With Greatbatch Medical 165
XII. 2.2 Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions 166
XII. 2.3 EndoStim Enters Into an Agreement With Arizona State University 167

XIII Recent Developments 168
XIII. 1 Company Vision and Strategy 168
XIII. 1.1 January 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes 168
XIII. 1.2 December 17, 2010: Accuray Establishes Medical Affairs Function 169
XIII. 1.3 November 09, 2010: Medtronic Opens New Distribution Center In Elizabeth, New Jersey 169
XIII. 1.4 November 02, 2010: InVivo Therapeutics Opens New Manufacturing And Development Facility In Medford, Massachusetts 169
XIII. 1.5 October 21, 2010: Collagen Matrix Expands Operations And Moves Corporate Headquarters To Oakland, New Jersey 170
XIII. 1.6 August 26, 2010: Pico-Tesla Opens New Facility In Michigan 170
XIII. 1.7 August 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection 171
XIII. 1.8 August 20, 2010: Integra Opens Center For Research, Education And Training In Irvine, California 171
XIII. 1.9 August 19, 2010: Boston Scientific To Invest In New Products: CEO 172
XIII. 1.10 August 10, 2010: CareFusion Announces Firms -Wide Restructuring 172
XIII. 1.11 June 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 172
XIII. 1.12 May 06, 2010: Swedish Cancer Institute And Elekta Renew Partnership Agreement 173
XIII. 1.13 April 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support 173
XIII. 2 Legal and Regulatory 174
XIII. 2.1 January 20, 2011: St. Jude Medical Reaches Settlement With DOJ 174
XIII. 2.2 January 11, 2011: Boston Scientific Reaches Settlement With Medinol 174
XIII. 2.3 December 09, 2010: Medtronic Receives Subpoena From US Government For Certain Neurostimulation Devices 174
XIII. 2.4 November 10, 2010: St. Jude Medical And AGA Medical Announce Early Termination Of HSR Waiting Period 175
XIII. 2.5 November 02, 2010: CSI Settles Employee Lawsuit With ev3 175
XIII. 2.6 September 23, 2010: St. Jude Medical Faces Derivative Suit From Shareholders 175
XIII. 2.7 August 10, 2010: Best Medical Files Patent Infringement Lawsuit Against Accuray 175
XIII. 2.8 July 12, 2010: Law Offices Of Howard G. Smith Investigates Micrus Acquisition For Shareholders 176
XIII. 2.9 July 06, 2010: ev3 Agrees To Settle Stockholder Litigation 176
XIII. 2.10 June 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3 176
XIII. 2.11 April 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific 176
XIII. 3 Government and Public Interest 177
XIII. 3.1 February 16, 2011: University Of Minnesota Researchers Receive US$ 3m Grants To Create Robotic Devices And Computer Vision Algorithms For Early Detection Of Childhood Mental Disorders 177
XIII. 3.2 February 15, 2011: May o Clinic Researchers Develop WINCS Device To Measure Brain Chemistry During Deep Brain Stimulation 178
XIII. 3.3 January 24, 2011: Deep Brain Stimulation May Help Hard-To-Control High Blood Pressure: Case Study 179
XIII. 3.4 January 18, 2011: Stents Help Stroke Victims When Other Treatments Fails: Research At ISET 179
XIII. 3.5 December 21, 2010: Boston Scientific Receives Notices Of Deficiency From IRS 180
XIII. 3.6 December 16, 2010: Researchers Suggest Diagnostic Criteria For Posttraumatic Stress Disorder Are Lacking 180
XIII. 3.7 November 29, 2010: Neuro Kinetics Earns Approval From Health Canada To Sell Diagnostic Devices In Canada 181
XIII. 3.8 November 14, 2010: Mental Introspection Increases As Brain Areas Begin To Act In Sync: Georgetown University Medical Center 182
XIII. 3.9 October 25, 2010: Radiation Therapy Improves Painful Condition Associated With MS: ASTRO 182
XIII. 3.10 October 08, 2010: Senator Grassley Questions VA Official's Relationship With Medtronic 183
XIII. 3.11 October 06, 2010: Salk Researchers Map Functional Connections Between Retinal Neurons At Single-Cell Resolution 183
XIII. 3.12 September 24, 2010: Scarless Brain Surgery Is New Option For Patients: UCSD And University Of Washington Study 185
XIII. 3.13 September 14, 2010: FDA Advisory Committee To Discuss Clinical Trial Design Issues For Neurological Devices 186
XIII. 3.14 September 08, 2010: SMU-Led Research Center Aims To Connect Brain Signals To Robotic Limbs 186
XIII. 3.15 August 25, 2010: Research Heralds Potential For Early Diagnosis Of Degenerative Brain Disorders 188
XIII. 3.16 August 22, 2010: Gene Scan Finds Link Across Array Of Childhood Brain Disorders 188
XIII. 3.17 August 11, 2010: Boston Scientific Resolves Corporate Warning Letter 190
XIII. 3.18 July 22, 2010: Stanford University School Of Medicine Seeks Patient Enrollment For Alzheimer's Study 190
XIII. 3.19 July 12, 2010: MRI Better Than CT Scans At Diagnosing Stroke: New Guideline 190
XIII. 3.20 June 30, 2010: New Study Identifies Best Tests For Predicting Alzheimer’s Disease: Study 191
XIII. 3.21 June 22, 2010: UCLA Brain Scanning Study Has Implications For Advertising, Public Health Campaigns 192
XIII. 3.22 June 03, 2010: Governor Designates Cleveland Health And Technology Corridor An Ohio Hub Of Innovation And Opportunity 193
XIII. 3.23 May 11, 2010: Stereotactic Radiosurgery Is Safe And Effective For Selected Children With Arteriovenous Malformations: May o Clinic 194
XIII. 3.24 May 04, 2010: Stereotactic Radiosurgery Successful For Most Patients With Large Acoustic Neuromas: May o Clinic 195
XIII. 3.25 May 03, 2010: Imaging Study Discovers Brain Development Differences In Kids With Fragile X Syndrome: Study 196
XIII. 3.26 April 30, 2010: Tiny Particles May Help Surgeons By March king Brain Tumors 197
XIII. 3.27 April 19, 2010: Surgeons Use Brain Port Device To Treat Brain Cyst 198
XIII. 3.28 April 18, 2010: Scientists Develop Brain-Recording Device To Control Seizures 199
XIII. 3.29 April 16, 2010: Clinical Study Shows Patients Gain Limb Movement Years After Stroke 200
XIII. 3.30 April 09, 2010: CDRH: Research Needed To Explore Side Effects Of Pediatric Devices 201
XIII. 3.31 April 01, 2010: UC Researchers Quantify Benefits Of Minimally Invasive Removal For Tumors 201
XIII. 4 Product News 203
XIII. 4.1 August 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference 203
XIII. 4.2 July 15, 2010: Elekta To Highlight Intelligent Cancer Management Solutions At 2010 AAPM Annual Meeting 203
XIII. 4.3 May 05, 2010: Terumo Announces Its Program For The World Embolization Symposium And Technologies (GEST) Meeting 204

XIV Appendix 205
XIV. 1 Definitions of March kets Covered in the Report 206
XIV. 1.1 Neurology Devices 206
XIV. 2 Research Methodology 209
XIV. 3 Secondary Research 209
XIV. 4 Primary Research 210
XIV. 5 Models 210
XIV. 6 Forecasted data s 211
XIV. 7 Expert Panels 211
XIV. 8 GlobalData Consulting 211
XIV. 9 Currency Conversion 211
XIV. 10 Contact Us 212
XIV. 11 Disclaimer 2

1.1 List of Data tables
Data table 1: Neurology Devices, United States, Overall Sales (USD Million), from 2003 to 2017 18
Data table 2: Neurology Devices March ket, United States, Segment Contribution (%), 2010 20
Data table 3: Neurology Devices, United States, Cross-Category Analysis, from 2003 to 2017 21
Data table 4: Neurology Devices, United States, Overall Sales (USD Million), Historical data, from 2003 to 2010 23
Data table 5: Neurology Devices, United States, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 25
Data table 6: Neurology Devices, United States, Segment Volume (Units), from 2003 to 2017 26
Data table 7: Neurology Devices, United States, Segment Volume (Units), Historical data, from 2003 to 2010 28
Data table 8: Neurology Devices, United States, Segment Volume (Units), Forecasted data, from 2010 to 2017 30
Data table 9: Neurology Devices, United States, Market Shares by Sales (USD Million), from 2009 to 2010 32
Data table 10: CSF Management March ket, United States, Segment Contribution (%), 2010 35
Data table 11: CSF Management, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 37
Data table 12: CSF Management, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 39
Data table 13: CSF Management, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 40
Data table 14: CSF Management, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 42
Data table 15: CSF Management, United States, Average Price ($), Historical data, from 2003 to 2010 43
Data table 16: CSF Management, United States, Average Price ($), Forecasted data, from 2010 to 2017 43
Data table 17: CSF Management, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 44
Data table 18: CSF Management, United States, Market Shares by Sales (USD Million), from 2009 to 2010 45
Data table 19: Interventional Neurology March ket, United States, Segment Contribution (%), 2010 48
Data table 20: Interventional Neurology, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 50
Data table 21: Interventional Neurology, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 52
Data table 22: Embolic Systems, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 54
Data table 23: Embolic Systems, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 56
Data table 24: Navigational Systems, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 58
Data table 25: Navigational Systems, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 60
Data table 26: Interventional Neurology, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 62
Data table 27: Interventional Neurology, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 64
Data table 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 65
Data table 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 66
Data table 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 67
Data table 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 69
Data table 32: Interventional Neurology, United States, Average Price ($), Historical data, from 2003 to 2010 71
Data table 33: Interventional Neurology, United States, Average Price ($), Forecasted data, from 2010 to 2017 71
Data table 34: Interventional Neurology, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 72
Data table 35: Interventional Neurology, United States, Market Shares by Sales (USD Million), from 2009 to 2010 74
Data table 36: Neurological Diagnostic Equipment March ket, United States, Segment Contribution (%), 2010 77
Data table 37: Neurological Diagnostic Equipment, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 79
Data table 38: Neurological Diagnostic Equipment, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 81
Data table 39: Neurological Diagnostic Equipment, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 83
Data table 40: Neurological Diagnostic Equipment, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 85
Data table 41: Neurological Diagnostic Equipment, United States, Average Price ($), Historical data, from 2003 to 2010 86
Data table 42: Neurological Diagnostic Equipment, United States, Average Price ($), Forecasted data, from 2010 to 2017 86
Data table 43: Neurological Diagnostic Equipment, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 87
Data table 44: Neurological Diagnostic Equipment, United States, Market Shares by Sales (USD Million), from 2009 to 2010 89
Data table 45: Neurostimulation Devices March ket, United States, Segment Contribution (%), 2010 92
Data table 46: Neurostimulation Devices, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 94
Data table 47: Neurostimulation Devices, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 96
Data table 48: Neurostimulation Devices, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 98
Data table 49: Neurostimulation Devices, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 100
Data table 50: Neurostimulation Devices, United States, Average Price ($), Historical data, from 2003 to 2010 101
Data table 51: Neurostimulation Devices, United States, Average Price ($), Forecasted data, from 2010 to 2017 101
Data table 52: Neurostimulation Devices, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 102
Data table 53: Neurostimulation Devices, United States, Market Shares by Sales (USD Million), from 2009 to 2010 104
Data table 54: Neurosurgical Products March ket, United States, Segment Contribution (%), 2010 107
Data table 55: Neurosurgical Products, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 109
Data table 56: Neurosurgical Products, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 111
Data table 57: Neurosurgical Products, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 112
Data table 58: Neurosurgical Products, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 114
Data table 59: Neurosurgical Products, United States, Average Price ($), Historical data, from 2003 to 2010 115
Data table 60: Neurosurgical Products, United States, Average Price ($), Forecasted data, from 2010 to 2017 115
Data table 61: Neurosurgical Products, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 116
Data table 62: Neurosurgical Products, United States, Market Shares by Sales (USD Million), from 2009 to 2010 118
Data table 63: Radiosurgery March ket, United States, Segment Contribution (%), 2010 121
Data table 64: Radiosurgery, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 123
Data table 65: Radiosurgery, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 125
Data table 66: Radiosurgery, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 127
Data table 67: Radiosurgery, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 128
Data table 68: Radiosurgery, United States, Average Price ($), Historical data, from 2003 to 2010 129
Data table 69: Radiosurgery, United States, Average Price ($), Forecasted data, from 2010 to 2017 129
Data table 70: Radiosurgery, United States, Distribution Channel by Sales (USD Million), from 2009 to 2010 130
Data table 71: Radiosurgery, United States, Market Shares by Sales (USD Million), from 2009 to 2010 131
Data table 72: Neurology Devices March ket Pipeline Products 143
Data table 73: Impulse Monitoring Takes Over Great Lakes Intraoperative Neuromonitoring 150
Data table 74: Boston Scientific Takes Over Remaining Stake In Intelect Medical 151
Data table 75: Vycor Medical Completes Acquisition Of November aVision 153
Data table 76: Synthes Takes Over The Anspach Effort 154
Data table 77: Stryker Takes Over Porex Surgical 155
Data table 78: Cardinal Health Sells 13.7% Stake In Carefusion 156
Data table 79: HealthMed Services Takes Over Neural Communicator 157
Data table 80: Masimo Completes Acquisition Of SEDLine 158
Data table 81: Johnson and Johnson Completes Acquisition Of Micrus Endovascular 159
Data table 82: K-Kitz Takes Over Bacterin In Reverse Acquisition 161
Data table 83: Medtronic Takes Over Axon Systems 162
Data table 84: Covidien Completes Acquisition Of ev3 For US$ 2.6 Bln 163
Data table 85: Boston Scientific Enters Into Partnership With Greatbatch Medical 165
Data table 86: Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions 166
Data table 87: EndoStim Concludes a New Deal With Arizona State University 167
Data table 88: US Dollar to Local Currency, United States, Average Actual Rate from 2003 to 2010 211

1.2 List of Charts

Chart 1: Neurology Devices, March ket Segmentation 16
Chart 2: Neurology Devices, United States, Overall Sales (USD Million), from 2003 to 2017 17
Chart 3: Neurology Devices March ket, United States, Sales Mix (USD Million), 2010 19
Chart 4: Neurology Devices March ket, United States, Segment Contribution (%), 2010 20
Chart 5: Neurology Devices, United States, Cross-Category Analysis, from 2003 to 2017 21
Chart 6: Neurology Devices, United States, Overall Sales (USD Million), Historical data, from 2003 to 2010 22
Chart 7: Neurology Devices, United States, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 24
Chart 8: Neurology Devices, United States, Segment Volume (Units), from 2003 to 2017 26
Chart 9: Neurology Devices, United States, Segment Volume (Units), Historical data, from 2003 to 2010 27
Chart 10: Neurology Devices, United States, Segment Volume (Units), Forecasted data, from 2010 to 2017 29
Chart 11: Neurology Devices, United States, Market Shares (%), 2010 31
Chart 12: CSF Management, March ket Segmentation 33
Chart 13: CSF Management March ket, United States, Sales Mix (USD Million), 2010 34
Chart 14: CSF Management March ket, United States, Segment Contribution (%), 2010 35
Chart 15: CSF Management, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 36
Chart 16: CSF Management, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 38
Chart 17: CSF Management, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 40
Chart 18: CSF Management, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 42
Chart 19: CSF Management, United States, Market Shares (%), 2010 45
Chart 20: Interventional Neurology, March ket Segmentation 46
Chart 21: Interventional Neurology March ket, United States, Sales Mix (USD Million), 2010 47
Chart 22: Interventional Neurology March ket, United States, Segment Contribution (%), 2010 48
Chart 23: Interventional Neurology, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 49
Chart 24: Interventional Neurology, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 51
Chart 25: Embolic Systems, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 53
Chart 26: Embolic Systems, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 55
Chart 27: Navigational Systems, United States, Sales (USD Million) by Sub-Segment, Historical data, from 2003 to 2010 57
Chart 28: Navigational Systems, United States, Sales (USD Million) by Sub-Segment, Forecasted data, from 2010 to 2017 59
Chart 29: Interventional Neurology, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 61
Chart 30: Interventional Neurology, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 63
Chart 31: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 65
Chart 32: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 66
Chart 33: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historical data, from 2003 to 2010 67
Chart 34: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecasted data, from 2010 to 2017 69
Chart 35: Interventional Neurology, United States, Market Shares (%), 2010 73
Chart 36: Neurological Diagnostic Equipment, March ket Segmentation 75
Chart 37: Neurological Diagnostic Equipment March ket, United States, Sales Mix (USD Million), 2010 76
Chart 38: Neurological Diagnostic Equipment March ket, United States, Segment Contribution (%), 2010 77
Chart 39: Neurological Diagnostic Equipment, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 78
Chart 40: Neurological Diagnostic Equipment, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 80
Chart 41: Neurological Diagnostic Equipment, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 82
Chart 42: Neurological Diagnostic Equipment, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 84
Chart 43: Neurological Diagnostic Equipment, United States, Market Shares (%), 2010 88
Chart 44: Neurostimulation Devices, March ket Segmentation 90
Chart 45: Neurostimulation Devices March ket, United States, Sales Mix (USD Million), 2010 91
Chart 46: Neurostimulation Devices March ket, United States, Segment Contribution (%), 2010 92
Chart 47: Neurostimulation Devices, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 93
Chart 48: Neurostimulation Devices, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 95
Chart 49: Neurostimulation Devices, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 97
Chart 50: Neurostimulation Devices, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 99
Chart 51: Neurostimulation Devices, United States, Market Shares (%), 2010 103
Chart 52: Neurosurgical Products, March ket Segmentation 105
Chart 53: Neurosurgical Products March ket, United States, Sales Mix (USD Million), 2010 106
Chart 54: Neurosurgical Products March ket, United States, Segment Contribution (%), 2010 107
Chart 55: Neurosurgical Products, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 108
Chart 56: Neurosurgical Products, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 110
Chart 57: Neurosurgical Products, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 112
Chart 58: Neurosurgical Products, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 114
Chart 59: Neurosurgical Products, United States, Market Shares (%), 2010 117
Chart 60: Radiosurgery, March ket Segmentation 119
Chart 61: Radiosurgery March ket, United States, Sales Mix (USD Million), 2010 120
Chart 62: Radiosurgery March ket, United States, Segment Contribution (%), 2010 121
Chart 63: Radiosurgery, United States, Sales (USD Million) by Sector, Historical data, from 2003 to 2010 122
Chart 64: Radiosurgery, United States, Sales (USD Million) by Sector, Forecasted data, from 2010 to 2017 124
Chart 65: Radiosurgery, United States, Volume (Units) by Sector, Historical data, from 2003 to 2010 126
Chart 66: Radiosurgery, United States, Volume (Units) by Sector, Forecasted data, from 2010 to 2017 128
Chart 67: Radiosurgery, United States, Market Shares (%), 2010 131
Chart 68: Medtronic, Inc., Market Shares (%),United States Neurology Devices March ket, 2010 132
Chart 69: Boston Scientific Corporation, Market Shares (%),United States Neurology Devices March ket, 2010 133
Chart 70: St. Jude Medical, Inc., Market Shares (%),United States Neurology Devices March ket, 2010 134
Chart 71: Cyberonics, Inc., Market Shares (%),United States Neurology Devices March ket, 2010 135
Chart 72: DePuy, Inc., Market Shares (%),United States Neurology Devices March ket, 2010 136
Chart 73: Integra LifeSciences Holdings Corporation, Market Shares (%),United States Neurology Devices March ket, 2010 137Medtronic, Inc.
Boston Scientific Corporation
St. Jude Medical, Inc.
Cyberonics, Inc.
DePuy, Inc.
Integra LifeSciences Holdings Corporation
Terumo Corporation
Nihon Kohden Corporation
Elekta AB
Micrus Endovascular Corporation
Cadwell Laboratories, Inc.
ev3 Inc.
B. Braun Melsungen AG
Mizuho Ikakogyo Co., Ltd.
Accuray Incorporated
CareFusion Corporation
Natus Medical Incorporated
Covidien plc
Sophysa S.A.
KARL STORZ GmbH and Co. KG

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Medical Specialty Bags Market

Global Medical Specialty Bags Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Medical Specialty Bags in US$ Thousands by the following Product Segments: Bile Collection Bags, Blood Bags, Breathing Bags, Cadaver Bags, Enema Bags, Enteral ...

Electrosurgery Market by Product - Generator, Electrosurgical Instruments (Vessel Sealing, Bipolar Forceps, Electrode, Suction Coagulator), Accessories, Surgery (General, Gynecology, Orthopedic, Cardiovascular, Cosmetic) - Global Forecasts to 2019

Electrosurgery Market by Product - Generator, Electrosurgical Instruments (Vessel Sealing, Bipolar Forceps, Electrode, Suction Coagulator), Accessories, Surgery (General, Gynecology, Orthopedic, Cardiovascular, Cosmetic) - Global Forecasts to 2019

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

The global electrosurgery market is estimated to grow at a CAGR of 5.9% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, U.K.) hold larger shares in the electrosurgery market, ...

Fluid Management & Visualization Systems Market by Product (Suction & Irrigation, Dialyzer, Fluid Warming & Waste Management, Endoscopic Camera, Tubing's, Bloodlines), & Application (GI, Urology, Arthroscopy, Gynecology) - Global Forecasts to 2018

Fluid Management & Visualization Systems Market by Product (Suction & Irrigation, Dialyzer, Fluid Warming & Waste Management, Endoscopic Camera, Tubing's, Bloodlines), & Application (GI, Urology, Arthroscopy, Gynecology) - Global Forecasts to 2018

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

The fluid management and visualization systems industry has evolved from traditional standalone systems to modern automated, integrated systems to increase the endosurgical procedure outcomes. Patient ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.